| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
43,058 |
39,645 |
$4.23M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
14,966 |
12,786 |
$4.11M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
44,577 |
40,268 |
$3.75M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
24,787 |
22,166 |
$2.22M |
| 70450 |
Computed tomography, head or brain; without contrast material |
10,192 |
9,444 |
$1.33M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,330 |
7,790 |
$1.25M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,991 |
11,159 |
$993K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
17,248 |
11,837 |
$884K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,530 |
2,338 |
$800K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,701 |
2,554 |
$765K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
6,627 |
5,537 |
$622K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,411 |
1,991 |
$526K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,885 |
2,744 |
$480K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,217 |
3,840 |
$468K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,346 |
1,215 |
$425K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
883 |
835 |
$383K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,410 |
4,174 |
$353K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,160 |
1,037 |
$342K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,391 |
2,282 |
$327K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,871 |
1,809 |
$320K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13,008 |
11,564 |
$311K |
| 76830 |
Ultrasound, transvaginal |
2,964 |
2,865 |
$227K |
| 80053 |
Comprehensive metabolic panel |
50,643 |
43,238 |
$217K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,133 |
6,592 |
$198K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,455 |
1,268 |
$171K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,633 |
3,493 |
$163K |
| 93971 |
|
1,951 |
1,847 |
$155K |
| 71046 |
Radiologic examination, chest; 2 views |
13,160 |
12,463 |
$146K |
| G0378 |
Hospital observation service, per hour |
5,108 |
4,191 |
$133K |
| 12001 |
|
780 |
730 |
$133K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
921 |
832 |
$123K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
413 |
397 |
$119K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
15,955 |
13,817 |
$115K |
| 76801 |
|
2,416 |
2,167 |
$114K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,929 |
2,861 |
$113K |
| 84484 |
|
27,416 |
20,025 |
$112K |
| 76642 |
|
1,564 |
1,277 |
$105K |
| 70496 |
|
720 |
686 |
$103K |
| 29125 |
|
509 |
483 |
$99K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
682 |
632 |
$80K |
| 96367 |
|
1,566 |
1,118 |
$76K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,250 |
1,146 |
$75K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
839 |
817 |
$70K |
| 12011 |
|
344 |
324 |
$60K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
25,453 |
22,933 |
$57K |
| 10060 |
|
275 |
267 |
$56K |
| 73030 |
|
4,236 |
3,791 |
$55K |
| 72100 |
|
4,341 |
4,158 |
$53K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
29,635 |
25,965 |
$52K |
| 83605 |
|
9,445 |
7,737 |
$49K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
134 |
132 |
$49K |
| 84145 |
|
5,960 |
5,328 |
$48K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,631 |
3,397 |
$46K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,861 |
1,666 |
$46K |
| 76770 |
|
597 |
575 |
$45K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
819 |
787 |
$43K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,488 |
10,522 |
$43K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,874 |
5,032 |
$42K |
| 73562 |
|
2,735 |
2,373 |
$42K |
| 90715 |
|
2,371 |
2,263 |
$40K |
| 70486 |
|
1,195 |
1,147 |
$39K |
| 73130 |
|
3,596 |
3,125 |
$39K |
| 95806 |
|
121 |
119 |
$38K |
| 80047 |
|
6,281 |
5,779 |
$36K |
| 73564 |
|
3,340 |
2,806 |
$36K |
| 71250 |
|
820 |
800 |
$36K |
| 73630 |
|
3,865 |
3,427 |
$35K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
193 |
187 |
$34K |
| 73610 |
|
3,656 |
3,328 |
$34K |
| 76536 |
|
440 |
430 |
$34K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
207 |
199 |
$34K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,102 |
2,957 |
$34K |
| 87040 |
|
5,546 |
2,843 |
$33K |
| 73560 |
|
1,637 |
1,237 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
71,537 |
58,363 |
$32K |
| 71045 |
Radiologic examination, chest; single view |
17,952 |
16,387 |
$31K |
| 72040 |
|
2,348 |
2,260 |
$30K |
| 83880 |
|
7,512 |
6,761 |
$30K |
| 93017 |
|
419 |
403 |
$30K |
| 73502 |
|
2,690 |
2,288 |
$30K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
19,660 |
16,207 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12,012 |
8,809 |
$26K |
| 73110 |
|
2,517 |
2,227 |
$25K |
| 70498 |
|
713 |
673 |
$25K |
| 12002 |
|
126 |
122 |
$24K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
238 |
219 |
$22K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,956 |
2,885 |
$22K |
| 10061 |
|
105 |
102 |
$20K |
| 80076 |
|
7,742 |
7,229 |
$20K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
150 |
141 |
$19K |
| 95811 |
|
55 |
55 |
$18K |
| 93970 |
|
182 |
173 |
$16K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
14,173 |
13,094 |
$16K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20,057 |
16,485 |
$15K |
| 74018 |
|
2,684 |
2,484 |
$15K |
| 77066 |
Tomosynthesis, mammo |
616 |
592 |
$15K |
| 85379 |
|
2,956 |
2,808 |
$15K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,542 |
3,166 |
$14K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
292 |
275 |
$13K |
| 70491 |
|
100 |
95 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
16,933 |
12,913 |
$10K |
| 83690 |
|
24,056 |
21,732 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,720 |
3,830 |
$9K |
| 77065 |
Tomosynthesis, mammo |
352 |
307 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
428 |
358 |
$8K |
| 84702 |
|
6,725 |
6,040 |
$7K |
| 73140 |
|
670 |
632 |
$7K |
| J1453 |
Injection, fosaprepitant, 1 mg |
220 |
120 |
$7K |
| 97597 |
|
206 |
127 |
$7K |
| 80143 |
|
1,469 |
1,327 |
$7K |
| 73590 |
|
1,077 |
946 |
$6K |
| 76870 |
|
99 |
92 |
$6K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,576 |
1,413 |
$6K |
| 72070 |
|
628 |
597 |
$5K |
| 84703 |
|
12,042 |
11,036 |
$5K |
| 80050 |
General health panel |
1,480 |
1,374 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,112 |
2,966 |
$5K |
| 95819 |
|
36 |
36 |
$5K |
| 81001 |
|
25,480 |
23,261 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,638 |
7,955 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,650 |
9,484 |
$4K |
| 73080 |
|
740 |
691 |
$4K |
| 82803 |
|
2,651 |
2,239 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
111 |
97 |
$4K |
| 83735 |
|
4,313 |
2,862 |
$4K |
| 82962 |
|
12,346 |
8,812 |
$4K |
| 80179 |
|
1,393 |
1,285 |
$4K |
| 85610 |
|
21,488 |
16,746 |
$3K |
| 72131 |
|
166 |
148 |
$3K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
157 |
144 |
$3K |
| 82728 |
|
1,196 |
1,108 |
$3K |
| 87070 |
|
5,552 |
5,095 |
$3K |
| 73070 |
|
204 |
190 |
$3K |
| 96368 |
|
242 |
198 |
$3K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
422 |
262 |
$3K |
| 82607 |
|
794 |
745 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,087 |
6,556 |
$3K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
27 |
24 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
11,238 |
9,397 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
10,117 |
7,483 |
$2K |
| 72141 |
|
13 |
13 |
$2K |
| 96376 |
|
5,643 |
4,072 |
$2K |
| G0384 |
Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
13 |
13 |
$2K |
| 81025 |
|
8,955 |
8,337 |
$2K |
| 73090 |
|
461 |
426 |
$2K |
| 76882 |
|
27 |
25 |
$2K |
| 81003 |
|
8,589 |
8,021 |
$2K |
| 86900 |
|
2,645 |
2,455 |
$2K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
1,580 |
1,475 |
$2K |
| 86850 |
|
1,322 |
1,243 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,797 |
3,942 |
$2K |
| 80051 |
|
2,345 |
2,194 |
$2K |
| 36591 |
|
764 |
529 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
40 |
38 |
$1K |
| 96523 |
|
79 |
66 |
$1K |
| 83550 |
|
958 |
884 |
$1K |
| 87430 |
|
3,147 |
2,948 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,422 |
2,291 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,983 |
4,587 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,017 |
2,429 |
$1K |
| 59025 |
Fetal non-stress test |
12 |
12 |
$1K |
| 84100 |
|
2,100 |
1,334 |
$1K |
| 83540 |
|
1,066 |
986 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,005 |
7,979 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,858 |
4,571 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,161 |
1,094 |
$1K |
| 71101 |
|
225 |
214 |
$1K |
| 82565 |
|
3,215 |
3,017 |
$1K |
| 85027 |
|
1,247 |
1,094 |
$1K |
| 86140 |
|
3,120 |
2,831 |
$1K |
| 97161 |
|
41 |
38 |
$1K |
| 86901 |
|
2,643 |
2,453 |
$1K |
| 87186 |
|
4,366 |
3,862 |
$1K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
6,010 |
5,451 |
$1K |
| 74022 |
|
281 |
272 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,756 |
1,521 |
$1K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
98 |
41 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,390 |
3,961 |
$970.30 |
| 0240U |
|
3,241 |
3,081 |
$943.78 |
| 71271 |
|
14 |
13 |
$780.41 |
| 84112 |
|
192 |
169 |
$765.42 |
| J2060 |
Injection, lorazepam, 2 mg |
3,934 |
3,374 |
$740.32 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,722 |
4,942 |
$715.45 |
| 73700 |
|
12 |
12 |
$686.58 |
| 82746 |
|
484 |
462 |
$683.17 |
| 90686 |
|
85 |
81 |
$626.13 |
| 82330 |
|
3,613 |
3,260 |
$621.45 |
| 82378 |
|
163 |
146 |
$587.03 |
| 82550 |
|
1,233 |
1,021 |
$569.73 |
| 94010 |
|
30 |
29 |
$564.88 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,478 |
1,312 |
$549.73 |
| 94729 |
|
42 |
42 |
$549.21 |
| 84443 |
Thyroid stimulating hormone (TSH) |
934 |
884 |
$525.02 |
| 87205 |
|
2,711 |
2,398 |
$520.27 |
| 97116 |
|
38 |
26 |
$492.28 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
31 |
27 |
$450.82 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
723 |
669 |
$439.18 |
| 87210 |
|
890 |
857 |
$412.77 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,310 |
3,729 |
$378.90 |
| J3490 |
Unclassified drugs |
183 |
119 |
$376.44 |
| 80061 |
Lipid panel |
150 |
140 |
$366.06 |
| 87510 |
|
39 |
38 |
$364.69 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
209 |
196 |
$353.76 |
| 87147 |
|
849 |
789 |
$350.78 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,448 |
4,323 |
$335.22 |
| 71100 |
|
43 |
40 |
$331.03 |
| 94726 |
|
27 |
27 |
$329.38 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
478 |
395 |
$322.06 |
| 82010 |
|
1,043 |
898 |
$319.52 |
| J1940 |
Injection, furosemide, up to 20 mg |
358 |
240 |
$313.20 |
| 11045 |
|
62 |
31 |
$289.91 |
| 77080 |
|
14 |
14 |
$277.49 |
| 87077 |
|
1,804 |
1,539 |
$270.30 |
| 85730 |
|
2,953 |
2,756 |
$269.58 |
| 97162 |
|
13 |
12 |
$260.50 |
| 93798 |
|
62 |
12 |
$250.08 |
| 85652 |
|
1,785 |
1,656 |
$249.64 |
| 82947 |
|
2,239 |
2,103 |
$248.60 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
934 |
725 |
$219.18 |
| G0008 |
Administration of influenza virus vaccine |
85 |
81 |
$214.63 |
| 87220 |
|
712 |
686 |
$205.24 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,582 |
1,378 |
$205.15 |
| 82075 |
|
191 |
169 |
$198.09 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
15 |
13 |
$194.47 |
| C9113 |
Injection, pantoprazole sodium, per vial |
202 |
134 |
$187.97 |
| 73620 |
|
17 |
13 |
$184.89 |
| 87660 |
|
39 |
38 |
$183.48 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
508 |
498 |
$182.68 |
| 81002 |
|
811 |
772 |
$181.62 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,489 |
1,762 |
$176.47 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
547 |
407 |
$108.39 |
| 83615 |
|
237 |
210 |
$107.92 |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,573 |
1,155 |
$103.55 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
250 |
218 |
$96.47 |
| 80164 |
|
12 |
12 |
$94.47 |
| 82553 |
|
15 |
12 |
$93.51 |
| 87807 |
|
475 |
442 |
$69.22 |
| J2785 |
Injection, regadenoson, 0.1 mg |
260 |
252 |
$64.00 |
| 0099U |
|
73 |
70 |
$56.39 |
| J3480 |
Injection, potassium chloride, per 2 meq |
520 |
377 |
$47.34 |
| A9270 |
Non-covered item or service |
21,269 |
13,266 |
$46.39 |
| 82248 |
|
232 |
217 |
$42.58 |
| 72170 |
|
13 |
12 |
$41.95 |
| 73060 |
|
15 |
14 |
$41.33 |
| 87428 |
|
192 |
190 |
$34.47 |
| 82140 |
|
47 |
41 |
$33.62 |
| 87480 |
|
39 |
38 |
$29.84 |
| 0352U |
|
195 |
189 |
$29.10 |
| 84132 |
|
90 |
67 |
$27.66 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,409 |
642 |
$27.52 |
| 88304 |
|
310 |
254 |
$25.22 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,111 |
1,008 |
$21.02 |
| 84550 |
|
109 |
102 |
$19.07 |
| 84439 |
|
12 |
12 |
$18.27 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
182 |
170 |
$16.46 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
317 |
270 |
$16.43 |
| 85014 |
|
81 |
63 |
$14.07 |
| 88342 |
|
377 |
327 |
$11.46 |
| 87340 |
|
26 |
25 |
$10.36 |
| 81015 |
|
32 |
32 |
$9.05 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
911 |
632 |
$8.95 |
| 82570 |
|
14 |
13 |
$8.42 |
| 86706 |
|
13 |
13 |
$7.50 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
104 |
95 |
$5.08 |
| 84156 |
|
15 |
14 |
$5.08 |
| 85018 |
|
91 |
76 |
$5.02 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
89 |
87 |
$4.91 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
214 |
182 |
$0.44 |
| J1815 |
Injection, insulin, per 5 units |
574 |
453 |
$0.18 |
| 87339 |
|
124 |
118 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
348 |
329 |
$0.00 |
| J1598 |
Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg |
47 |
42 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
32 |
30 |
$0.00 |
| 96417 |
|
296 |
169 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
529 |
519 |
$0.00 |
| 99152 |
|
150 |
141 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
104 |
81 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
65 |
61 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
46 |
38 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
81 |
75 |
$0.00 |
| 70360 |
|
12 |
12 |
$0.00 |
| G0238 |
Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring) |
162 |
147 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
281 |
276 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
209 |
184 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
162 |
148 |
$0.00 |
| C1769 |
Guide wire |
273 |
251 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
15 |
12 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
111 |
65 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
243 |
219 |
$0.00 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
204 |
110 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
29 |
29 |
$0.00 |
| J1836 |
Injection, metronidazole, 10 mg |
41 |
25 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
17 |
16 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
52 |
48 |
$0.00 |